Literature DB >> 2875815

Long term therapy by captopril in children with renal hypertension.

F Bouissou, B Meguira, M Rostin, C Fontaine, J P Charlet, P Barthe.   

Abstract

We report on 29 treatment courses in 25 children aged 1.5-18 years who received captopril because of severe renal hypertension. The mean initial dosage was 1.3 (0.5 to 3) mg/kg/day and the mean sustaining dose 2.2 mg/kg/day. The treatment was followed for 2-40 (mean 15) months. We observed a lowering of both systolic and diastolic blood pressure (BP) from 26% at the 2nd day to 65% at the 6th month. The isolated use of captopril was ineffective in 13% of cases, but blood pressure dropped in all of them after addition of beta blocking agents. No clear-cut relation was found between response of blood pressure and etiology, degree of HT or plasma renin activity (PRA). No side effects occurred during treatment except for one case of reversible acute renal failure in a transplanted patient with renal artery stenosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875815     DOI: 10.3109/10641968609046602

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  5 in total

Review 1.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 2.  Pharmacologic treatment of chronic pediatric hypertension.

Authors:  Renee F Robinson; Milap C Nahata; Donald L Batisky; John D Mahan
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 3.  Angiotensin-converting enzyme inhibitors in chronic renal failure.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 5.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.